NovaBridge Biosciences Net Cash Provided by (Used in) Investing Activities, Continuing Operations
NovaBridge Biosciences (NBP) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $104.97 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2026-04-07
- NovaBridge Biosciences net cash provided by (used in) investing activities, continuing operations for the quarter ending 2025-12-31 was $0.00.
- NovaBridge Biosciences net cash provided by (used in) investing activities, continuing operations for the quarter ending 2025-09-30 was $0.00.
- NovaBridge Biosciences net cash provided by (used in) investing activities, continuing operations for the quarter ending 2024-12-31 was -$109.00K.
- NovaBridge Biosciences net cash provided by (used in) investing activities, continuing operations for the quarter ending 2024-09-30 was -$81.66M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | $0.00 derived: sum of 2 quarters · filed 2026-04-07 | $104.97M 20-F · filed 2026-04-07 | |
| 2025-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | $104.97M 6-K · filed 2025-12-18 | ||
| 2025-06-30 | $104.97M 6-K · filed 2025-10-06 | |||
| 2024-12-31 | -$109.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | -$81.76M derived: sum of 2 quarters · filed 2026-04-07 | -$136.01M 20-F · filed 2026-04-07 | |
| 2024-09-30 | -$81.66M derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | -$135.91M 6-K · filed 2025-12-18 | ||
| 2024-06-30 | -$54.25M 6-K · filed 2025-10-06 | |||
| 2023-12-31 | -$15.16M 20-F · filed 2026-04-07 | |||
| 2022-12-31 | -$5.18M 20-F · filed 2025-04-03 |